Feb 15, 2021 | News
https://www.mthightech.org/news/inimmune-biotech-case-study
Feb 15, 2021 | News
<https://www.bassmaster.com/news/nation-angler-evans-helping-vital-covid-research?j=23264113&sfmc_sub=1646391083&l=4168516_HTML&u=507970617&mid=10688361&jb=0>
Oct 2, 2020 | News
Inimmune is a collaborator in the University of Montana’s effort to bring opioid vaccines to clinical trials.
Jul 9, 2020 | News
(Missoula, MT) Inimmune, www.inimmune.com, a biotechnology company developing immune therapies and components for more effective vaccines, announced today that it raised $22 million in Series A funding. It was the Missoula-based company’s first outside...
Jul 9, 2020 | News
Inimmune lands the an $22 million dollar investment, let by Two Bear Capital. The investment is believed to be largest Series A funding in state history; Inimmune, which is based in Missoula, Montana, specializes in adjuvants for vaccines and has been developing a...
Jul 1, 2020 | News
Inimmune Corporation, a biotechnology company located in Missoula, MT, was recently awarded a $2 M grant from the National Institute for Allergy and Infectious Diseases (NIAID) under its Small Business Innovation Research (SBIR) Direct to Phase II program to advance a...
